Latest Beta amyloid Stories
Researchers say they have been working with a tiny yet promising new drug-like molecule that could lead to a preventative treatment for Alzheimer’s disease.
Researchers in Berlin and Munich, Germany and Oxford, United Kingdom, have revealed that a protein well known for its role in Alzheimer's disease controls spindle development in muscle and leads to impaired movement in mice when the protein is absent or treated with inhibitors.
Eli Lilly & Co has ended a clinical trial for an Alzheimer's disease drug during the middle of the study after patients showed abnormal liver biochemical tests.
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease.
Researchers have found that the brains of patients with early-onset Alzheimer's produce about 20 percent more of a protein fragment known as amyloid beta 42 than family members without the disease.